New Treatment Options Emerge for Gastroparesis Management
Gastroparesis, or paralysis of the stomach, is a condition of the digestive system that is
Surabhi Dangi-Garimella PhD
August 29, 2022
Category: Biologics
New Interchangeable Biosimilar for Insulin Approved: What It Means for Diabetics
A new biosimilar product, the first one for insulin, has been approved by the Food
Surabhi Dangi-Garimella PhD
August 11, 2021
Biosimilars: What is Interchangeability, Reference Product, and Why You Should Care
Recently, I had a conversation with a small group of patients from the #PatientsRisingFam about
Jim Sliney Jr.
August 11, 2021
Patients Rising Asks: Why Are Rheumatologists Hesitant to Switch Patients to Biosimilars?
Results from an online survey (Medscape.com) of board-certified U.S. rheumatologists found reluctance to switch patients
Surabhi Dangi-Garimella PhD
February 9, 2021
Know Your Options: Innovations in Migraine Treatment
Learn about new classes of drugs to prevent and treat migraines, as well as options to reduce their frequency.
Surabhi Dangi-Garimella PhD
May 7, 2020
Biologics for Asthma: Fixing the Future
Might biologics be the answer to the asthma problem?
Jim Sliney Jr, Editor
December 7, 2018
Biosimilar Medications: What Psoriasis and Psoriatic Arthritis Patients Need to Know
The hottest topic now for psoriasis and psoriatic arthritis patients are the new psoriasis biosimilar treatments.
Jim Sliney Jr, Editor
September 7, 2017